Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sangel Capital, also known as Shenzhen Sangel Venture Capital Co., Ltd., is one of the earliest professional biomedical venture capital firms in China. Founded in Shenzhen, the firm operates globally with offices in Shenzhen, Beijing, Suzhou, and Chicago. It manages a series of RMB and USD funds, establishing a strong position in the biomedical investment industry.
Sangel Capital specializes in the life sciences sector, investing in innovative growth enterprises that demonstrate significant capital value and commercial potential. The firm seeks to cultivate industry benchmarks in promising industries, focusing on companies that can lead advancements in healthcare and biotechnology.
Sangel Capital has backed several notable companies in the life sciences sector, including Funo Biotech, recognized in the 2021 Venture50 list by Qianlong and Investment界; Suyuan Biotech, which is collaborating with QIAGEN on diagnostic kits; and Huaxia Yingtai, awarded as one of the top 20 most technologically advanced enterprises by the Shenzhen Angel Fund in 2021.
Email your pitch deck to sangel@sangelvc.com for consideration.
Yes, Sangel Capital often leads investment rounds in the companies they back, particularly in the life sciences sector.
The firm is open to follow-on investments, especially in companies that demonstrate strong growth and potential for further development.
While specific fund sizes are not disclosed, Sangel Capital manages multiple RMB and USD funds aimed at supporting life sciences ventures.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.